Abstract
Selective targeting of cancer stem cells (CSCs) has the potential to prevent cancer relapse. Wang etal. (2011) report that hypoxia-inducible factor 1α (HIF1α) represses Notch signaling to maintain CSC subsets from lymphoma, and that blocking HIF1α activity eliminates lymphoma and human acute myeloid leukemia (AML) CSCs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have